Home › All Companies › AWHL › Annual Report

Aspira Women's Health Inc. (AWHL) — Annual Report

AI-Powered SEC Filing Analysis

← All AWHL filings
Latest Annual Report Filed: 2026-04-01

Key Insights

  • Aspira Women's Health Inc. reported a significant increase in additional paid-in capital in 2025 compared to 2024, potentially indicating capital raises or equity financing activities.
  • The company modified the terms of its August 2022 warrants in 2025, which could impact the company's financial position and warrant valuations.
  • Aspira extended its equity line of credit agreement with Lincoln Park Capital Fund in 2025, providing additional financing flexibility.
Sentiment: Neutral Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-01. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Aspira Women's Health Inc.

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.